TOGA Post ASCO Symposium:

Thoracic Cancer Highlights and Satellite Symposium

When?

Tuesday 17th, June 2025

What Time?

6:30pm - 8:15pm AEST

Where?

Online

About the TOGA Virtual Symposium

The Thoracic Oncology Group of Australasia (TOGA) presents the thoracic cancer highlights from the 2025 ASCO Annual Meeting. Presenters will discuss the major findings in thoracic cancers presented at this international meeting and the expected influence on local practice.

 

PROGRAM 

Chair:  Dr Laird Cameron

6:30 PM – 8:15 PM AEST

Time

Topic

Speaker

6:30 PM – 6:35 PM

Session Introduction

Dr Laird Cameron

Medical Oncologist

Te Puriri o Te Ora, Te Whatu Ora Te Toka Tumai Auckland

6:35 PM – 6:55 PM

Early-Stage Lung Cancer

A/Prof Rachel Roberts-Thomson

Medical Oncologist

The Queen Elizabeth Hospital and Cancer Care Adelaide

6:55 PM – 7:15 PM

Advanced-Stage Lung Cancer

Dr Alex Davis

Medical Oncologist

Northern Sydney Cancer Centre

7:15 PM – 7:35 PM

SCLC

Dr Lavinia Tan

Medical Oncologist

Peter MacCallum Cancer Centre

7:35 PM – 7:50 PM

Poster Picks: What Caught Our Eye at ASCO

Dr Malinda Itchins

Medical Oncologist

Royal North Shore Hospital and Chris O'Brien Lifehouse

7:50 PM – 8:10 PM

Panel Discussion

All Speakers

8:10 PM – 8:15 PM

Closing

Dr Laird Cameron

 

Register Today!

Chair:

Dr Laird Cameron

Medical Oncologist, Te Puriri o Te Ora, Te Whatu Ora Te Toka Tumai Auckland

Dr Laird Cameron is a Medical Oncologist specialising in thoracic malignancies.

Laird completed a clinical fellowship in lung and head & neck malignancies at the Peter MacCallum Cancer Centre in Melbourne, Australia in 2016. He then returned to New Zealand and has been caring for patients with thoracic cancers in Auckland at Te Puriri o Te Ora, Auckland Hospital and Canopy Cancer Care since 2016. He is the current New Zealand representative on the TOGA scientific committee, past chair and founding member of NZ Lung Oncology Special Interest Group, current president of the New Zealand Society for Oncology and senior lecturer in the Department of Oncology at the University of Auckland. His research interests include lung cancer, equity and precision oncology.

Presenters:

Dr Alex Davis

Medical Oncologist, Northern Sydney Cancer Centre

Dr Alex Davis is a medical oncologist with an interest in thoracic malignancies. His focus includes biomarker directed therapy, personalised medicine and patient centred decision making. He is a strong believer in clinical trials improving patient outcomes and is an active participant in several industry and TOGA led clinical trials. He is currently enrolled in a PhD at the University looking at KRAS mutant lung cancer and how co-mutations mediate clinical outcomes to immunotherapy and KRAS directed therapy.

Dr Malinda Itchins

Medical Oncologist, Royal North Shore Hospital and Chris O'Brien Lifehouse

Dr Malinda Itchins BMedSci, MBBS(Hons1), FRACP, PhD, is a thoracic medical oncologist at Royal North Shore Hospital, and Chris O'Brien Lifehouse, Sydney. She is a senior clinical lecturer with the University of Sydney and Board Director with the Clinical Oncology Society of Australia (COSA). Malinda is Co-Chair of the Advanced NSCLC Group on the Scientific Committee of the Thoracic Oncology Group of Australasia (TOGA), and passionate trialist, researcher and advocate for improving care for all people affected by lung cancer.

A/Prof Rachel Roberts-Thomson

Medical Oncologist, The Queen Elizabeth Hospital and Cancer Care Adelaide

Rachel is a Medical Oncologist in Adelaide, South Australia with a strong interest in treating patients with thoracic malignancies as well as melanoma. She enjoys being a Principal Investigator on clinical trials, clinical research projects as well as supervising and teaching. Her focus has been on immuno-therapeutics and targeted therapies with the excitement that exists in the field.

Dr Lavinia Tan

Medical Oncologist, Peter MacCallum Cancer Centre

Dr Lavinia Tan is a Medical Oncologist with a sub-speciality interest in treating patients with lung cancer. She completed a clinical fellowship focusing on thoracic malignancies at the Peter MacCallum Cancer Centre and a laboratory-based PhD in the Molecular Biomarkers and Translational Genomics Laboratory exploring the utility of circulating tumour DNA to guide precision medicine in solid malignancies. Lavinia’s main research interests focus on understanding and developing novel strategies to overcome resistance to targeted therapies in oncogene driven lung cancers.

 

Sponsored by:

This event has now concluded.
We are using a temporary cookie to streamline your experience. No personal data is stored and the cookie is removed once you complete your registration.

Your Browser Settings have Cookies Disabled

This site requires a temporary cookie to streamline your experience. No personal data is stored and the cookie will be removed once you complete your registration. Please enable cookies in your browser and refresh this page.